26 Feb 2017 | 11:11 AM
 

AstraZeneca Pharma India Ltd. Share Price Live (BSE)
0

BSE Code: 506820 | NSE Symbol: ASTRAZEN
917.25
1.95
(0.22 %)
23 Feb 2017 | 04:01 PM
Change company
  • Open (Rs)
    919.00
  • Prev. close (Rs.)
    915.30
  • High (Rs.)
    924.00
  • Low (Rs.)
    910.00
  • 52W H (Rs.)
    1,314.00
  • 52W L (Rs.)
    910.00
  • Volume (Rs.)
    12182
  • MCap (Rs in Cr.)
    2,293.13
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

News

02 Dec 2016 - 12:48:00-AstraZeneca Pharma India said that it has got an extension from its parent firm AstraZeneca UK to se...
25 Aug 2016 - 11:25:00-Shares of AstraZeneca Pharma India plunged nearly 8 per cent on the Bombay Stock Exchange after the ...
10 Aug 2016 - 12:18:00-Shares of AstraZeneca Pharma soared over 11 per cent on the Bombay Stock Exchange after drug maker r...
08 Feb 2016 - 16:00:00-Drug major AstraZeneca Pharma India Ltd reported that it swung to profit at Rs 8...

Announcements

24-Feb-2017
AstraZeneca Pharma I - Updates on Registrar & Share Transfer Agent division (RTA)
06-Feb-2017
AstraZeneca Pharma India Ltd. - Reply to Clarification Sought
03-Feb-2017
AstraZeneca Pharma I - Outcome of Board Meeting
03-Feb-2017
AstraZeneca Pharma I - Standalone Financial Results Limited Review Report for December 31 2016
03-Feb-2017
AstraZeneca Pharma India Ltd. - Clarification

Religare Research

23 Feb 2017 | 06:00 PM
This week, we haven’t initiated fresh position, keeping in mind overbought market conditions and num...
23 Feb 2017 | 06:00 PM
Nifty index settled on a positive note for the fifth successive week, hitting 52 week high on the la...
23 Feb 2017 | 12:45 PM
VIP Industries (VIP) reported in-line numbers for Q3FY17 with a revenue and PAT growth of 5.5% & 43....
23 Feb 2017 | 11:15 AM
Agri Fundamental report

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
4,32,431 50.40 22.95 0.14
4,32,431 50.40 225.75 0.14
4,32,431 50.40 37.38 0.14
4,32,431 50.40 21.97 0.14
4,32,431 50.40 232.98 0.14

Shareholding Pattern

       
Promotors75.00%
Mutual Funds/UTI7.14%
FI/Banks0.02%
Insurance0.02%
FII4.70%
Government0.00%
Others1.84%

Peer Group

Company Intraday Graph
 Kovai Medical Center and Hospital Ltd.
1,119.90(2.32)
11816
 Merck Ltd.
1,087.80(-0.35)
3302
 Neuland Laboratories Ltd.
903.35(0.04)
3578
 TTK Healthcare Ltd.
842.00(2.73)
3392

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Astrazeneca Pharma India Ltd.-42.35-21.15-207.60
NIFTY(S&P CNX)548.00906.20306.90
BSE SENSEX1,775.632,841.16902.76
BSE 500763.721,333.78587.62

Corporate Details

Key Personal
D E Udwadia
Chairman
Kimuska Narsimhan
Addnl.Independent Director
Sanjay Murdeshwar
Managing Director
Key Address
Registered Office
Avishkar Off Bellary Road Hebbal,Bangalore,Karnataka

Tel:080-23622020 23622021 23622022 67748000, Fax:080-23622015

comp.secy@astrazeneca.com
http://www.astrazenecaindia.com
Registrar Office
Integrated Enterprises (India) Ltd.
Add. :1st Floor Kences Towers No. 1 Ramakrishna Street North Usman Road T Nagar

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for AstraZeneca Pharma India Ltd. that will help you decide whether to buy, sell or hold AstraZeneca Pharma India Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against AstraZeneca Pharma India Ltd.